HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S-adenosyl-L-methionine (SAMe) as an adjunct for resistant major depressive disorder: an open trial following partial or nonresponse to selective serotonin reuptake inhibitors or venlafaxine.

AbstractBACKGROUND:
The purpose of this open trial was to evaluate the safety, tolerability, and efficacy of oral S-adenosyl-L-methionine as an antidepressant adjunct among partial and nonresponders to serotonin reuptake inhibitors or venlafaxine.
METHOD:
Thirty antidepressant-treated adult outpatients with persisting major depressive disorder received 800 to 1600 mg of S-adenosyl-L-methionine tosylate over a 6-week trial.
RESULTS:
Intent-to-treat analyses based on the Hamilton Depression Rating Scale revealed a response rate of 50% and a remission rate of 43% following augmentation with S-adenosyl-L-methionine. Gastrointestinal symptoms and headaches were the most common side effects.
CONCLUSION:
Augmentation of selective serotonin reuptake inhibitors or venlafaxine with S-adenosyl-L-methionine warrants a placebo-controlled trial in resistant depression.
AuthorsJonathan E Alpert, George Papakostas, David Mischoulon, John J Worthington 3rd, Timothy Petersen, Yasmin Mahal, Alana Burns, Teodoro Bottiglieri, Andrew A Nierenberg, Maurizio Fava
JournalJournal of clinical psychopharmacology (J Clin Psychopharmacol) Vol. 24 Issue 6 Pg. 661-4 (Dec 2004) ISSN: 0271-0749 [Print] United States
PMID15538131 (Publication Type: Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article)
Chemical References
  • Cyclohexanols
  • Serotonin Uptake Inhibitors
  • adenosyl-methionine 1,4-butanedisulfonate
  • Venlafaxine Hydrochloride
  • S-Adenosylmethionine
Topics
  • Adult
  • Cyclohexanols (therapeutic use)
  • Depressive Disorder, Major (drug therapy, psychology)
  • Drug Therapy, Combination
  • Female
  • Humans
  • Male
  • Middle Aged
  • Psychiatric Status Rating Scales (statistics & numerical data)
  • S-Adenosylmethionine (analogs & derivatives, therapeutic use)
  • Selective Serotonin Reuptake Inhibitors (therapeutic use)
  • Venlafaxine Hydrochloride

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: